Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Aclaris Therapeutics (ACRS) Return on Assets: 2017-2025

Historic Return on Assets for Aclaris Therapeutics (ACRS) over the last 8 years, with Sep 2025 value amounting to -0.80%.

  • Aclaris Therapeutics' Return on Assets fell 57.00% to -0.80% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.80%, marking a year-over-year decrease of 57.00%. This contributed to the annual value of -0.63% for FY2024, which is 24.00% down from last year.
  • Per Aclaris Therapeutics' latest filing, its Return on Assets stood at -0.80% for Q3 2025, which was down 11.44% from -0.71% recorded in Q2 2025.
  • In the past 5 years, Aclaris Therapeutics' Return on Assets ranged from a high of -0.22% in Q3 2024 and a low of -0.80% during Q3 2025.
  • In the last 3 years, Aclaris Therapeutics' Return on Assets had a median value of -0.48% in 2023 and averaged -0.52%.
  • As far as peak fluctuations go, Aclaris Therapeutics' Return on Assets soared by 31bps in 2024, and later tumbled by 57bps in 2025.
  • Over the past 5 years, Aclaris Therapeutics' Return on Assets (Quarterly) stood at -0.35% in 2021, then remained steady at -0.34% in 2022, then dropped by 10bps to -0.45% in 2023, then declined by 22bps to -0.67% in 2024, then tumbled by 57bps to -0.80% in 2025.
  • Its Return on Assets stands at -0.80% for Q3 2025, versus -0.71% for Q2 2025 and -0.64% for Q1 2025.